Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis

Back

HFA Premium Access

Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis

Session: Novelties in amyloid cardiomyopathy

Topic: Clinical

Speaker: Doctor V. Castiglione (Pisa, IT) Doctor G. Vergaro (Pisa, IT)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speakers

Doctor Vincenzo Castiglione

Sant'Anna School of Advanced Studies, Pisa (Italy)

2 presentations

0 follower

Doctor Giuseppe Vergaro

Sant'Anna School of Advanced Studies, Pisa (Italy)

8 presentations

0 follower

3 more presentations in this session

Use and safety of sodium-glucose cotransporter 2 inhibitors in a prospective cohort of patients with transthyretin amyloid cardiomyopathy.

Speaker: Doctor M. Maccallini (Milan, IT)

Phenotypic expression and outcomes of cardiomyopathy caused by titin truncating variants: translational insights

Speaker: Doctor M. Perotto (Trieste, IT)

Prognostic value of tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/SPAP) ratio in amyloid cardiomyopathy

Speaker: Doctor M. Maccallini (Milan, IT)

Access the full session

Novelties in amyloid cardiomyopathy

Speakers: Doctor V. Castiglione, Doctor G. Vergaro, Doctor M. Maccallini, Doctor M. Perotto, Doctor M. Maccallini

Access

Video

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources